Early diagnosis needed for young adults with lung cancer

Topics under discussion at the WCLC 2022 presidential symposium

Atezolizumab vs best supportive care in resected NSCLC

Working to improve global cancer care access in low middle-income countries

Impact of BRAF-V600E mutation on the tumour microenvironment and associated genomic alterations in colorectal cancer

Prostate cancer screening: A novel risk prediction tool with standard biopsies vs PSA with MRI-targeted biopsies

Low-dose nivolumab leads to improved overall survival for head and neck cancer patients

Palbociclib shows improved PFS but not improved OS for ER+ HER2- mBC patients

Updates from the PROpel and MAGNITUDE studies

Update on the latest in PARP inhibitors for prostate cancer

Isatuximab + Pd in Difficult-to-Treat Patients with RRMM

ASCO Direct Highlights 2022: prostate cancer highlights